Global foundation awards Texas Biomed $1 million to conduct large-scale rodent testing of human monoclonal antibodies to combat SARS-CoV-2
Texas Biomedical Research Institute (Texas Biomed) in San Antonio, Texas, was awarded $1 million from the Bill & Melinda Gates Foundation to test the efficacy of human monoclonal antibodies (MAbs) for the treatment of SARS-CoV-2 infection. MAbs are...
19-Nov-2020 9:00 AM EST Add to Favorites
NIH Grant aims to enhance scientific models of aging focused on creating better intervention tools for age-related decline
The Southwest National Primate Research Center (SNPRC) at Texas Biomedical Research Institute and the University of Texas Health Science Center at San Antonio received a $1.3 million collaborative grant to continue the San Antonio Marmoset Aging...
5-Nov-2020 1:05 PM EST Add to Favorites
Texas Biomed with the University of Alabama at Birmingham and Aridis Pharmaceuticals develop a neutralizing human monoclonal antibody against SARS-CoV-2
Texas Biomedical Research Institute (Texas Biomed) Professor Luis Martinez-Sobrido, Ph.D., recently released study findings, alongside colleagues at the University of Alabama at Birmingham and Aridis Pharmaceuticals, Inc. indicating that a human...
19-Oct-2020 8:35 AM EDT Add to Favorites
Scientists at Texas Biomed develop new tool to aid in the development of SARS-CoV-2 antivirals and vaccines
Researchers apply a novel reverse genetics approach to create recombinant SARS-CoV-2San Antonio, Texas (October 1, 2020) – Researchers at Texas Biomedical Research Institute (Texas Biomed) recently published findings from an innovative SARS-CoV-2...
1-Oct-2020 9:40 AM EDT Add to Favorites
Squirrel monkeys have been identified as a new animal model to further study and improve therapies for hepatitis B infection caused by the hepatitis B virus (HBV). Christopher Chen, Ph.D., Assistant Director for Research at the Southwest National...
9-Sep-2020 9:30 AM EDT Add to Favorites
The leadership team at Texas Biomedical Research Institute is excited to announce the addition of Akudo Anyanwu, M.D., M.P.H. to its administrative leadership team as Vice President of Development.
5-Aug-2020 10:25 AM EDT Add to Favorites
Scientists at Texas Biomed establish a human transgenic mouse model susceptible to SARS-CoV-2 infection
Texas Biomedical Research Institute (Texas Biomed) scientists have added another tool to the COVID-19 toolbelt, validating a new small animal model for studying SARS-CoV-2, the virus that causes COVID-19.
23-Jul-2020 11:20 AM EDT Add to Favorites
Fueling transformative research through collaboration, the San Antonio Partnership for Precision Therapeutics (SAPPT) announces the funding of three more collaborative COVID-19 research efforts in San Antonio. SAPPT has awarded more than $600,000 to...
9-Jul-2020 9:30 AM EDT Add to Favorites
See All News
Researcher on TB and the Intersection of Aging and Immune Function Joins Texas Biomed as Vice President for Research
Joanne Turner, Ph.D., a preeminent scientist in tuberculosis (TB) research, has joined the Texas Biomed team, bringing with her a portfolio of research on the immune system in relation to Mycobacterium tuberculosis infection and aging.
19-Oct-2017 1:05 PM EDT